Supported by the National Institutes of Health (R00-NS067050, R01NS094681, P30AG010129; Bethesda, MD, USA), American Heart Association (11IRG5440002; Dallas, TX, USA), the Glaucoma Research Foundation Catalyst for a Cure Biomarker Initiative (San Francisco, CA, USA), and Research to Prevent Blindness, Inc. (New York, NY, USA).
Disclosure: C. Leahy, None; H. Radhakrishnan, None; G. Weiner, None; J.L. Goldberg, None; V.J. Srinivasan, P